A patient empowerment program for primary immunodeficiency improves quality of life in children and adolescents

Maria Fasshauer, Gesine Schuermann, Norbert Gebert, Horst von Bernuth, Monika Bullinger, Sigune Goldacker, Renate Krueger, Petra Manzey, Stefanie Messner, Ellen D. Renner, Henrike Ritterbusch, Uwe Schauer, Ilka Schulze, Volker Umlauf, Steffi Widmann, Ulrich Baumann

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Aim: To assess a patient empowerment program (PEP) for children/adolescents with primary immunodeficiency (PID) on IgG replacement therapy regarding quality of life (QoL) in patients and proxy. Patients & methods: Health-related QoL was assessed using KIDSCREEN-27 and DISABKIDS-37 before and 6 months after PID-PEP kids in 19 children/adolescents and their parents. Results: The following three dimensions of the KIDSCREEN-27 significantly increased in children/adolescents after PID-PEP kids as compared with baseline: Psychological Well-Being, Parents & Autonomy and School Environment. Total DISABKIDS-37 index, as well as 5 of the 6 DISABKIDS-37 dimensions, significantly increased, in other words, Independence, Emotion, Social Inclusion, Social Exclusion and Physical. Evaluation of proxy instruments showed comparable results. Conclusion: PID-PEP kids significantly improved QoL in patients with PID.

Original languageEnglish
Pages (from-to)813-819
Number of pages7
JournalImmunotherapy
Volume16
Issue number12
DOIs
StatePublished - 2024

Keywords

  • DISABKIDS-37
  • IgG replacement therapy
  • KIDSCREEN-27
  • education program
  • inborn errors of immunity
  • patient empowerment program
  • primary immunodeficiency
  • quality of life

Fingerprint

Dive into the research topics of 'A patient empowerment program for primary immunodeficiency improves quality of life in children and adolescents'. Together they form a unique fingerprint.

Cite this